Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Urokinase Plasminogen Activator Receptor-PET with Ga-NOTA-AE105: First Clinical Experience with a Novel PET Ligand

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Imaging of Prostate Cancer Using Urokinase-Type Plasminogen Activator Receptor PET

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Clinical PET/MR Imaging in Dementia and Neuro-Oncology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical PET/MR Imaging in Oncology: Future Perspectives

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. PET/MR Imaging: Clinical Applications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. PET/MR Imaging in Musculoskeletal Disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Urokinase plasminogen activator receptor (uPAR) is a key component in proteolysis and extracellular matrix degradation during cancer invasion and metastasis. uPAR overexpression is an important biomarker for aggressiveness in several solid tumors and provides independent clinical information. A recent major breakthrough was obtained with human translation of uPAR PET using 68Ga-NOTA-AE105. Clinical results are encouraging and several large-scale clinical trials are now ongoing. This review focuses on uPAR PET with 68Ga-NOTA-AE105 as a new broadly applicable diagnostic and prognostic imaging biomarker in cancer.

OriginalsprogEngelsk
TidsskriftPET Clinics
Vol/bind12
Udgave nummer3
Sider (fra-til)311-319
Antal sider9
ISSN1556-8598
DOI
StatusUdgivet - jul. 2017

ID: 55064515